Wroblewski, LE, Peek, RM, Wilson, KT.
Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clinical Microbiology Reviews
2007; 23: 713–739.
Nurgalieva, ZZ, et al.
B-cell and T-cell immune responses to experimental Helicobacter pylori infection in humans. Infection Immunity
2005; 73: 2999–3006.
Kao, CY, Sheu, BS, Wu, JJ.
Helicobacter pylori infection: an overview of bacterial virulence factors and pathogenesis. Biomedical Journal
2016; 39: 14–23.
Hopkins, RJ, Girardi, LS, Turney, EA. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology
1996; 110: 1244–1252.
Yakoob, J, et al.
Helicobacter pylori outer membrane protein Q allele distribution is associated with distinct pathologies in Pakistan. Infection Genetics and Evolution
2016; 37: 57–62.
Helicobacter pylori infection and gastric lymphoma. British Medical Bulletin
1998; 54: 79–85.
Falush, D, et al.
Traces of human migrations in Helicobacter pylori populations. Science
2003; 299: 1582–1585.
Kersulyte, D, et al.
Differences in genotypes of Helicobacter pylori from different human populations. Journal of Bacteriology
2000; 182: 3210–3218.
Achtman, M, et al.
Recombination and clonal groupings within Helicobacter pylori from different geographical regions. Molecular Microbiology
1999; 32: 459–470.
Morelli, G, et al.
Microevolution of Helicobacter pylori during prolonged infection of single hosts and within families. PLoS Genetics
2010; 6: e1001036.
Kennemann, L, et al.
Helicobacter pylori genome evolution during human infection. Proceeding of National Academy of Sciences USA
2011; 108: 5033–5038.
Ilver, D, et al.
Helicobacter pylori adhesin binding fucosylated-histo blood group antigens revealed by retagging. Science
1998; 279: 373–377.
Loh, JY, et al.
Helicobacter pylori HopQ outer membrane protein attenuates bacterial adherence to gastric epithelial cells. FEMS Microbiology Letter
2008; 289: 53–58..
Lehours, P, et al.
Identification of a genetic marker of Helicobacter pylori strains involved in gastric extranodal marginal zone B-cell lymphoma of the MALT-type. Gut
2004; 53: 931–937.
Pereira, MI, Medeiros, JA. Role of Helicobacter pylori in gastric mucosa-associated lymphoid tissue lymphomas. World Journal of Gastroenterology
2014; 20: 684–698.
Yakoob, J, et al.
Distribution of gastric carcinoma in an area with a high prevalence of Helicobacter pylori
. Turk Journal of Gastroenterology
2017; 28: 98–103.
Nakamura, S, Müller-Hermelink, HK. Tumors of the stomach. In: Bosman, FT, Carneiro, F, Hruban, RH, Theise, ND, eds. WHO Classification of Tumors of the Digestive System, 4th edn.
Lyon, France: IARC (International Agency for Research on Cancer), 2010, pp. 45–80.
Isaacson, PG. Recent developments in our understanding of gastric lymphomas. American Journal Surgical Pathology
1996; 20(Suppl. 1): S1–S7.
de Jong, D, et al.
Histological grading in gastric lymphoma: pretreatment criteria and clinical relevance. Gastroenterology
1997; 112: 1466–1474.
Price, AB. The Sydney system: histological division. Journal of Gastroenterology Hepatology
1991; 6: 209–222.
Van Zwet, AA, et al.
Sensitivity of culture compared with that of polymerase chain reaction for detection of Helicobacter pylori from antral biopsy samples. Journal of Clinical Microbiology
1993; 31: 1918–1920.
Yakoob, J, et al.
Distribution of Helicobacter pylori virulence markers in patients with gastroduodenal diseases in Pakistan. BMC Gastroenterology
2009; 9: 87.
Cao, P, Cover, TL. Two different families of HopQ alleles in Helicobacter pylori
. Journal of Clinical Microbiology
2005; 40: 4504–4511.
Ferreri, AJ, Montalbán, C. Primary diffuse large B-cell lymphoma of the stomach. Critical Review Oncology Hematology
2007; 63: 65–71.
Yakoob, J, et al.
Polymerase chain reaction in the detection of Helicobacter pylori infection. Journal of College of Physicians Surgeons Pakistan
2004; 14: 153–156.
Fan, X, et al.
The effect of class II major histocompatibility complex expression on adherence of Helicobacter pylori and induction of apoptosis in gastric epithelial cells: a mechanism for T helper cell type 1-mediated damage. Journal of Experimental Medicine
1998; 187: 1659–1669.
Bland, DA, et al.
H. pylori receptor MHC-class II contributes to the dynamic gastric epithelial apoptotic response. World Journal of Gastroenterology
2006; 12: 5306–5310.
Hafsi, N, et al.
Human dendritic cells respond to Helicobacter pylori, promoting NK cell andTh1-effector responses in vitro. Journal of Immunology
2004; 173: 1249–1257.
Javaheri, A, et al.
Helicobacter pylori adhesin HopQ engages in a virulence enhancing interaction with human CEACAMs. Nature Microbiology
2016; 2: 161891.
Bussiere, FI, et al.
Low multiplicity of infection of Helicobacter pylori suppresses apoptosis of B lymphocytes. Cancer Research
2006; 66: 6834–6842.
Delchier, JC, et al.
Helicobacter pylori and gastric lymphoma: high seroprevalence of CagA in diffuse large B-cell lymphoma but not in low-grade lymphoma of mucosa- associated lymphoid tissue type. American Journal of Gastroenterology
2001; 96: 2324–2328.
Liu, H, et al.
T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology
2002; 122: 1286–1294.
Yeh, KH, et al.
Nuclear expression of BCL10 or nuclear factor kappa B helps predict Helicobacter pylori-independent status of low-grade gastric mucosa-associated lymphoid tissue lymphomas with or without t (11; 18)(q21;q21). Blood
2005; 106: 1037–1041.
Peng, H, et al.
High frequency of CagA+ Helicobacter pylori infection in high-grade gastric MALT B-cell lymphomas. Journal of Pathology
1998; 185: 409–412.
Eck, M, et al.
MALT-type lymphoma of the stomach is associated with Helicobacter pylori strains expressing the CagA protein. Gastroenterology
1997; 112: 1482–1486.
Sumida, T, et al.
Antibodies to Helicobacter pylori and CagA protein are associated with the response to antibacterial therapy in patients with H. pylori-positive API2-MALT1- negative gastric MALT lymphoma. Cancer Science
2009; 100: 1075–1081.
Umehara, S, et al.
Effects of Helicobacter pylori CagA protein on the growth and survival of B lymphocytes, the origin of MALT lymphoma. Oncogene
2003; 22: 8337–8342.
Loh, JT, et al.
Analysis of cagA in Helicobacter pylori strains from Colombian populations with contrasting gastric cancer risk reveal a biomarker for disease severity. Cancer Epidemiology Biomarkers Prevention
2011; 20: 2237–2249.
Yakoob, J, et al.
Low prevalence of the intact cag pathogenicity island in clinical isolates of Helicobacter pylori in Karachi, Pakistan. British Journal of Biomedical Science
2009; 66: 137–142.
Meyer-ter-Vehn, T, et al.
Helicobacter pylori activates mitogen-activated protein kinase cascades and induces expression of the proto-oncogenes c-fos and c-jun. Journal of Biological Chemistry
2000; 275: 16064–16072.
Owen, RJ, et al.
Investigation of the biological relevance of Helicobacter pylori cagE locus diversity, presence of CagA tyrosine phosphorylation motifs and vacuolating cytotoxin genotype on IL-8 induction in gastric epithelial cells. FEMS Immunology Medical Microbiology
2003; 36: 135–140.
Fronzes, R, Christie, PJ, Waksman, G. The structural biology of type IV secretion systems. Nature Reviews Microbiology
2009; 7: 703–714.
Gorrell, RJ, et al.
A novel NOD1- and CagA-independent pathway of interleukin-8 induction mediated by the Helicobacter pylori type IV secretion system. Cell Microbiology
2013; 15: 554–570.
Fischer, W, et al.
Systematic mutagenesis of the Helicobacter pylori cag-pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin-8. Molecular Microbiology
2001; 42: 1337–1348.
Koehler, CI, et al.
Helicobacter pylori genotyping in gastric adenocarcinoma and MALT lymphoma by multiplex PCR analyses of paraffin wax embedded tissues. Molecular Pathology
2003; 56: 36–42.
Torres, VJ, et al.
Helicobacter pylori vacuolating cytotoxin inhibits activation-induced proliferation of human T and B lymphocyte subsets. Journal of Immunology
2007; 179: 5433–5440.
Boncristiano, M, et al.
The Helicobacter pylori vacuolating toxin inhibits T cell activation by two independent mechanisms. Journal of Experimental Medicine
2003; 198: 1887–1897.
Sundrud, MS, et al.
Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion. Proceedings of National Academy of Sciences USA
2004; 101: 7727–7732.
Salama, NR, et al.
Vacuolating cytotoxin of Helicobacter pylori plays a role during colonization in a mouse model of infection. Infection and Immunity
2001; 69: 730–736.